Literature DB >> 8021092

Treatment of cutaneous leishmaniasis with oral itraconazole.

E Van den Enden1, A Van Gompel, A Stevens, N Vandeghinste, D Le Ray, P Gigase, K De Beule, J Van den Ende.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8021092     DOI： 10.1111/j.1365-4362.1994.tb01049.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  3 in total

1.  Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients.

Authors:  G Angarano; P Maggi; S L Coppola; R L Cavaliere
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267

2.  Primary oral Penicillium marneffei infection diagnosed by PCR-based molecular identification and transmission electron microscopic observation from formalin-fixed paraffin-embedded tissues.

Authors:  Xia Hua; Ruifeng Zhang; Hanjun Yang; Song Lei; Yizhi Zhang; Yuping Ran
Journal:  Med Mycol Case Rep       Date:  2012-11-07

Review 3.  Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis.

Authors:  Endi Lanza Galvão; Ana Rabello; Gláucia Fernandes Cota
Journal:  PLoS One       Date:  2017-10-09       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.